KyungAh Im
Impact in
-
- Diabetes Treatment and Management
- Diabetes Management and Research
-
- Antiplatelet Therapy and Cardiovascular Diseases
- Acute Myocardial Infarction Research
Papers in
-
- Diabetes Treatment and Management 20
- Diabetes, Cardiovascular Risks, and Lipoproteins 2
-
- Antiplatelet Therapy and Cardiovascular Diseases 15
- Acute Myocardial Infarction Research 4
- Cardiovascular Function and Risk Factors 3
- Co-authors
- Deepak L. Bhatt (33 shared papers)Ofri Mosenzon (20 shared papers)Marc Steven Sabatine (25 shared papers)Itamar Raz (18 shared papers)Darren K. McGuire (11 shared papers)Avivit Cahn (11 shared papers)Marc P. Bonaca (14 shared papers)Lawrence A. Leiter (9 shared papers)
- Journals
- Journal of the American College of Cardiology (11 papers)Circulation (8 papers)European Heart Journal (7 papers)JAMA Cardiology (5 papers)Diabetes Care (4 papers)
- Partner nations
- United StatesUnited KingdomSweden
In The Last Decade
KyungAh Im
58 papers receiving 8.4k citations
KyungAh Im's Hit Papers
Peers
Comparison fields: 5 of 112
- Endocrinology, Diabetes and Metabolism 3.8k
- Cardiology and Cardiovascular Medicine 3.0k
- Internal Medicine 387
- Surgery 2.6k
- Nephrology 349
Countries citing papers authored by KyungAh Im
This map shows the geographic impact of KyungAh Im's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by KyungAh Im with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites KyungAh Im more than expected).
Fields of papers citing papers by KyungAh Im
This network shows the impact of papers produced by KyungAh Im. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by KyungAh Im. The network helps show where KyungAh Im may publish in the future.
Co-authors
The 25 scholars most cited alongside KyungAh Im, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 59 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials Hit paper breakdown → | 2018 | 2160 |
| 2 | Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction Hit paper breakdown → | 2015 | 1528 |
| 3 | Lipoprotein(a), PCSK9 Inhibition, and Cardiovascular Risk Hit paper breakdown → | 2019 | 727 |
| 4 | Comparison of the Effects of Glucagon-Like Peptide Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors for Prevention of Major Adverse Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus Hit paper breakdown → | 2019 | 633 |
| 5 | Heart Failure, Saxagliptin, and Diabetes Mellitus: Observations from the SAVOR-TIMI 53 Randomized Trial Hit paper breakdown → | 2014 | 608 |
| 6 | Impact of Diabetes Mellitus on Hospitalization for Heart Failure, Cardiovascular Events, and Death Hit paper breakdown → | 2015 | 408 |
| 7 | Effect of Darapladib on Major Coronary Events After an Acute Coronary Syndrome Hit paper breakdown → | 2014 | 372 |
| 8 | 2016 | 220 | |
| 9 | 2016 | 169 | |
| 10 | 2014 | 141 | |
| 11 | 2019 | 137 | |
| 12 | 2015 | 128 | |
| 13 | Sodium-Glucose Cotransporter-2 Inhibitors and Major Adverse Cardiovascular Outcomes: A SMART-C Collaborative Meta-Analysis Hit paper breakdown → | 2024 | 100 |
| 14 | 2017 | 95 | |
| 15 | 2016 | 86 | |
| 16 | 2016 | 78 | |
| 17 | 2021 | 76 | |
| 18 | 2019 | 74 | |
| 19 | 2017 | 67 | |
| 20 | 2019 | 67 |
About KyungAh Im
KyungAh Im is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine, Surgery, Nephrology and Hepatology, having authored 59 papers that have together received 8.8k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (20 papers), Antiplatelet Therapy and Cardiovascular Diseases (15 papers), Lipoproteins and Cardiovascular Health (5 papers), Acute Myocardial Infarction Research (4 papers), Peripheral Artery Disease Management (3 papers), Cardiovascular Function and Risk Factors (3 papers), Coronary Interventions and Diagnostics (3 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (3.8k citations), Cardiology and Cardiovascular Medicine (3.0k citations), Internal Medicine (387 citations), Surgery (2.6k citations) and Nephrology (349 citations). KyungAh Im has collaborated with scholars based in United States, United Kingdom and Sweden. Frequent co-authors include Deepak L. Bhatt, Ofri Mosenzon, Marc Steven Sabatine, Itamar Raz, Darren K. McGuire, Avivit Cahn, Marc P. Bonaca, Lawrence A. Leiter, Erica L. Goodrich and Remo Holanda de Mendonça Furtado. Their work appears in journals such as Journal of the American College of Cardiology, Circulation, European Heart Journal, JAMA Cardiology and Diabetes Care.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.